Joe Leach, MD, discusses how comprehensive biomarker testing has impacted treatment selection for patients with small cell lung cancer. Joe Leach, MD, medical oncologist, associate medical director ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

SAN ANTONIO, December 12, 2024--bioAffinity reports successful execution of its pilot marketing program and steady growth in ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated ...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that the Norwegian healthcare region Helse Nord RHF will expand its usage of Sectra's enterprise imaging ...

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for ...

A study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunotherapy ...

A study from the University of Michigan Health Rogel Cancer Center may have, at last, cracked the cold case of immunotherapy resistance.The research ...

Types Of Lung Cancer Common In Non-Smokers Dr Pandey explained that the most common lung cancer type in non-smokers is adenocarcinoma, a form of Non-Small Cell Lung Cancer (NSCLC). It typically ...

Squamous cell carcinoma (SCC) in the lung is one form of non-small cell lung cancer. Non-small cell lung cancers account for about 85% of lung cancers, many of them associated with smoking. Of these, ...

1Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. 2Oncode Institute, Utrecht, the Netherlands.